RPS7

Small ribosomal subunit protein eS7 · P62081 · RPS7 on Sugi Atlas →

3,508 patent compounds predicted against RPS7, 1,806 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

Compound	Confidence	Supporting neighbours
SCHEMBL5500526	0.41	4/20
SCHEMBL5500532	0.41	4/20
SCHEMBL5503310	0.41	4/20
SCHEMBL11844361	0.35	4/20
SCHEMBL2000440	0.39	3/20
SCHEMBL8219903	0.36	3/20
SCHEMBL11627320	0.34	3/20
SCHEMBL6394396	0.47	2/20
N-Methylpiperidine (SCHEMBL11205373)	0.42	2/20
Bicarbonate (SCHEMBL9058396)	0.42	2/20
SCHEMBL4960293	0.41	2/20
SCHEMBL4961968	0.40	2/20
SCHEMBL6686992	0.40	2/20
SCHEMBL9429122	0.38	2/20
Chloramphenicol (SCHEMBL10796001)	1.00	1/20
Geneticin (SCHEMBL15596)	0.93	1/20
Geneticin (SCHEMBL5006573)	0.93	1/20
Geneticin (SCHEMBL9920496)	0.93	1/20
Chloramphenicol (SCHEMBL16111)	0.90	1/20
Chloramphenicol (SCHEMBL49057)	0.90	1/20

Clinical trials — most relevant to RPS7 by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
Proteome-based Personalized Immunotherapy of Glioblastoma	PHASE2/PHASE3	UNKNOWN
Proteome-based Immunotherapy of Lung Cancer Brain Metastases	PHASE2/PHASE3	UNKNOWN
Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients	PHASE2	COMPLETED
Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer	PHASE1/PHASE2	COMPLETED
Everolimus for Children With Recurrent or Progressive Ependymoma	PHASE2	COMPLETED
Mobilization of Stem Cells With G-CSF for Collection From Patients With Diamond-Blackfan Anemia	PHASE2	COMPLETED
Study of Decitabine in Combination With Sequential Rapamycin or Ribavirin in High Risk AML Patients	PHASE1/PHASE2	COMPLETED
Sirolimus Treatment in Patients With Autosomal Dominant Polycystic Kidney Disease: Renal Efficacy and Safety	PHASE2	COMPLETED
Prospective Phase II Randomized Trial of Postoperative Adjuvant Chemotherapy in Patients With High Risk Colon Cancer	PHASE2	UNKNOWN
ISIS 183750 With Irinotecan for Advanced Solid Tumors or Colorectal Cancer	PHASE1/PHASE2	COMPLETED
Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma	PHASE1/PHASE2	COMPLETED
Assessing the Safety, Tolerability, and Efficacy of APR-2020 in Pediatric and Adolescent Subjects With RPS19 Deficient Diamond-Blackfan Anemia	PHASE1	RECRUITING
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma	PHASE1	COMPLETED
Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer	PHASE1	WITHDRAWN
Effect of Branched Chain Amino Acids on Muscle	nan	COMPLETED
Personalized Medicine Program on Myelodysplastic Syndromes: Characterization of the Patient's Genome for Clinical Decision Making and Systematic Collection of Real World Data to Improve Quality of Health Care	nan	COMPLETED
RibOSE - Glucose and Resistance Exercise Training	nan	COMPLETED
Mobilization of CD34+ Peripheral Blood Stem Cells in Patients With Diamond Blackfan Anemia Syndrome (DBAS)	nan	RECRUITING
Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML)	nan	COMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy	nan	UNKNOWN
Role of RPL8 Protein Alterations in High-grade Serous Ovarian Carcinoma	nan	RECRUITING
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma	nan	COMPLETED
Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to 5-Fluorouracil Based Chemotherapy in Stage III Colon Cancer	nan	UNKNOWN
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis	nan	COMPLETED
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus	nan	COMPLETED
Autophagy in Systemic Lupus Erythematosus	nan	UNKNOWN
The Effects of Whey vs. Collagen on MPS	nan	COMPLETED
Diagnosis of RSTS: Identification of the Acetylation Profiles as Epigenetic Markers for Assessing Causality of CREBBP and EP300 Variants.	nan	UNKNOWN
miR-155 Expression in Episodic and Chronic Migraine	nan	UNKNOWN
Protein Intake and Step Reduction in Older Adults	nan	COMPLETED

Related proteins — ESM-2 sequence neighbours (a RPS7 binder may also engage these)

Protein	Name	Similarity
G1SVB0	—	1.000	G1SVB0 →
A6H769	—	1.000	A6H769 →
Q5RT64	—	1.000	Q5RT64 →
P62083	—	1.000	P62083 →
P62082	—	1.000	P62082 →
P02362	—	0.999	P02362 →
P62084	—	0.990	P62084 →
Q90YR7	—	0.988	Q90YR7 →
P50894	—	0.983	P50894 →
Q4R5I3	—	0.942	Q4R5I3 →
G1TU13	—	0.942	G1TU13 →
P63273	—	0.941	P63273 →
F1QGW6	—	0.940	F1QGW6 →
Q5R797	—	0.940	Q5R797 →
Q2KHU8	—	0.940	Q2KHU8 →
Q5ZMS3	—	0.940	Q5ZMS3 →
RPL22	Large ribosomal subunit protein eL22	0.939	landscape →
A5PK63	—	0.939	A5PK63 →
Q2VIR3	—	0.939	Q2VIR3 →
Q90YQ6	—	0.939	Q90YQ6 →
Q6QAP7	—	0.938	Q6QAP7 →
P63275	—	0.938	P63275 →
P63276	—	0.938	P63276 →
P63274	—	0.938	P63274 →
P41091	—	0.938	P41091 →
P81795	—	0.937	P81795 →
Q7ZUB2	—	0.937	Q7ZUB2 →
P08636	—	0.937	P08636 →
Q9CXU9	—	0.936	Q9CXU9 →
Q4R4X9	—	0.936	Q4R4X9 →